Moderna's Comeback Catalysts

Jim explains Moderna's 72% Q1 gain tied to legal settlements and vaccine pipeline progress.

Play episode from 17:26

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!